GO:0023025 MHC class Ib protein complex binding: Mechanism, Genes and Research Methods

Research-grade guide for scientists and biopharma professionals

Key Takeaways

GO:0023025 defines the molecular function of binding to a class Ib major histocompatibility complex (MHC) protein [1, 5].
MHC class Ib molecules are nonclassical MHC proteins that present antigens and interact with immune receptors such as NK cell receptors [1, 5, 6].
Key class Ib genes include HLA-E, H2-Q10, and TL in mice, which are recognized by receptors like Ly49C and CD94/NKG2 [1, 3, 8].
This binding function is critical for immune surveillance, tumor immunity, and pathogen response [3, 6, 8].
Dysregulation of MHC class Ib interactions is implicated in cancer, autoimmunity, and infectious diseases [1, 8].
CRISPR-based models (KO, point mutation, knock-in, overexpression) enable precise dissection of MHC class Ib binding mechanisms [1, 3].

Description

MHC class Ib protein complex binding (GO:0023025) is a molecular function that describes the specific interaction between a protein and a nonclassical major histocompatibility complex (MHC) class Ib molecule [1, 5]. Unlike classical MHC class Ia molecules, class Ib proteins such as HLA-E in humans and H2-Q10 or TL in mice exhibit limited polymorphism and specialized roles in immune recognition [1, 3, 8]. This binding function is essential for immune surveillance, as it mediates interactions with natural killer (NK) cell receptors and other immune effectors [1, 5]. Understanding this function is crucial for researchers studying antigen presentation, NK cell education, and tumor immunology [3, 6, 8]. The QuickGO definition states that this term encompasses binding to a class Ib major histocompatibility complex, highlighting its role in molecular recognition events that underpin immune responses [1, 5].

MHC class Ib protein complex binding At A Glance

GO ID GO:0023025
GO term MHC class Ib protein complex binding
Ontology molecular_function
Synonym None
Major function Binding to nonclassical MHC class Ib proteins, mediating immune recognition and antigen presentation [1, 5]
Related genes HLA-E, H2-Q10, TL, Ly49C, CD94/NKG2 [1, 3, 8]
Associated diseases Cancer, autoimmunity, infectious diseases [1, 8]
Research methods CRISPR knockout, point mutation, knock-in, overexpression, structural biology [1, 3]

What Is GO:0023025?

GO:0023025 is a molecular function term defined as the binding to a class Ib major histocompatibility complex protein [1, 5]. It encompasses the physical interaction between a protein and MHC class Ib molecules, which are nonclassical MHC proteins involved in antigen presentation and immune regulation [1, 6].

Why Is MHC class Ib protein complex binding Important in Cell Biology?

MHC class Ib protein complex binding is vital for immune system function because it enables the recognition of nonclassical MHC molecules by receptors on NK cells and T cells, thereby regulating immune activation and tolerance [1, 5]. This binding function is implicated in diverse physiological and pathological processes, including tumor immune evasion, viral infections, and autoimmune disorders [1, 3, 8]. Studying this molecular function provides insights into fundamental immune mechanisms and offers potential therapeutic targets for immunotherapy [1, 8].
Mediates NK cell recognition and education through interactions with class Ib molecules like HLA-E [1, 5].
Plays a role in antigen presentation by nonclassical MHC class Ib molecules.
Involved in tumor immunity, as class Ib molecules such as TL can act as tumor-specific antigens.
Contributes to immune surveillance against pathogens, including viruses and bacteria [3, 6].
Dysregulation is associated with autoimmune diseases and cancer progression [1, 8].
Provides a target for immunotherapeutic interventions, such as checkpoint blockade.
Structural studies reveal mechanisms of receptor-ligand interactions [1, 3].
Genetic polymorphisms in class Ib genes affect binding specificity and immune response [4, 7].
CRISPR screening can identify novel binding partners and pathways [1, 3].
Bioinformatics tools help predict MHC class Ib binding peptides and interactions [1, 6].

What Happens During MHC class Ib protein complex binding?

Recognition of MHC class Ib by Immune Receptors
In simple terms: Immune receptors on NK cells or T cells recognize and bind to MHC class Ib molecules.
The binding of MHC class Ib protein complexes to receptors such as Ly49C or CD94/NKG2 is a key event in immune recognition [1, 3, 5]. Structural studies have revealed that HLA-E, a human MHC class Ib molecule, presents a limited set of peptides to NK cell receptors, leading to either activation or inhibition of NK cells. Similarly, the mouse class Ib molecule H2-Q10 is recognized by the Ly49C receptor, demonstrating species-specific interactions.
Antigen Presentation by MHC Class Ib Molecules
In simple terms: MHC class Ib molecules present antigens to immune cells, similar to classical MHC molecules but with distinct properties.
MHC class Ib molecules such as TL and H2-Q10 can present antigens to T cells, although their peptide repertoire is more restricted than that of classical MHC class Ia [6, 8]. This antigen presentation can lead to T cell activation or tolerance, depending on the context. The binding of these complexes to T cell receptors or NK receptors modulates immune responses [6, 8].
Signal Transduction Upon Binding
In simple terms: Binding triggers signals inside the immune cell that alter its behavior.
Upon binding of MHC class Ib complexes to receptors, intracellular signaling pathways are activated, often involving immunoreceptor tyrosine-based inhibitory motifs (ITIMs) or activation motifs (ITAMs). These signals regulate NK cell cytotoxicity, cytokine production, and proliferation. For example, engagement of HLA-E with CD94/NKG2A delivers inhibitory signals that prevent NK cell activation against healthy cells.
Regulation of Immune Tolerance and Activation
In simple terms: The balance between inhibitory and activating signals determines whether immune cells attack or tolerate a target.
MHC class Ib protein complex binding is central to the calibration of immune responses, ensuring tolerance to self while enabling elimination of infected or transformed cells [1, 5]. Dysregulation of these interactions can lead to autoimmunity or immune evasion by tumors [1, 8]. The expression levels and peptide cargo of class Ib molecules influence the outcome of receptor engagement [1, 6].

Key Genes Involved in GO:0023025 MHC class Ib protein complex binding

The following genes encode proteins involved in MHC class Ib protein complex binding, including class Ib molecules themselves and their receptors.
GeneMajor RoleResearch Relevance
HLA-EHuman MHC class Ib molecule; presents peptides to NK receptorsKey target for NK cell immunotherapy and cancer research
H2-Q10Mouse MHC class Ib molecule; recognized by Ly49CModel for studying NK cell recognition and viral immunity
TL (Tla)Mouse MHC class Ib molecule; tumor-specific antigenStudied in tumor immunology and T cell responses
Ly49CMouse NK cell receptor for H2-Q10Investigates inhibitory signaling and NK cell education
CD94Forms heterodimer with NKG2; binds HLA-EHuman NK receptor complex; target for immune modulation [1, 5]
NKG2AInhibitory receptor for HLA-ECheckpoint target in cancer immunotherapy
NKG2CActivating receptor for HLA-ERole in viral infections and NK cell activation
B2MBeta-2-microglobulin; light chain of MHC class IEssential for MHC class Ib surface expression
TAP1Transporter associated with antigen processingPeptide loading onto MHC class Ib
TAP2Transporter associated with antigen processingPeptide loading onto MHC class Ib
ERAP1Endoplasmic reticulum aminopeptidaseTrims peptides for MHC class Ib presentation
HLA-GHuman MHC class Ib molecule; immune toleranceRole in maternal-fetal tolerance and cancer
HLA-FHuman MHC class Ib moleculeLess studied; potential immune regulation
MICAMHC class I polypeptide-related sequence AStress-induced ligand for NKG2D
MICBMHC class I polypeptide-related sequence BStress-induced ligand for NKG2D
ULBP1UL16 binding protein 1NKG2D ligand; viral evasion
RAET1Retinoic acid early transcript 1Mouse NKG2D ligand
H2-T23Mouse MHC class Ib gene (Qa-1b)Presents peptides to CD94/NKG2

How Is MHC class Ib protein complex binding Regulated?

The expression and function of MHC class Ib molecules are regulated at multiple levels, including transcriptional control by cytokines and stress signals. For example, interferon-gamma upregulates classical MHC class I but has variable effects on class Ib genes. Post-translational regulation includes peptide loading and chaperone interactions in the endoplasmic reticulum. Additionally, the binding affinity of MHC class Ib complexes to their receptors can be modulated by the peptide cargo and glycosylation state [1, 3].

MHC class Ib protein complex binding and Human Disease

GeneDisease / BiologyPotential Experimental Model
HLA-ECancer immune evasion; autoimmunityKnockout in human cell lines; overexpression in mouse tumor models
H2-Q10Viral infection (MCMV)Knockout mice; point mutations in binding interface
TLTumor immunologyTransgenic mice; knockout of TL expression
HLA-GMaternal-fetal tolerance; cancerKnock-in humanized mice; overexpression in trophoblast cells
B2MMHC class I deficiencyKnockout in cell lines; patient-derived mutations
MHC Class Ib in Cancer
MHC class Ib molecules such as HLA-E and HLA-G are often overexpressed in tumors and contribute to immune evasion by inhibiting NK cell and T cell responses [1, 8]. The binding of HLA-E to CD94/NKG2A on NK cells delivers inhibitory signals that prevent tumor cell killing. Targeting this interaction with checkpoint inhibitors is a promising therapeutic strategy. In mice, the TL antigen is a tumor-specific antigen that can elicit T cell responses, highlighting the dual role of class Ib molecules in cancer.
MHC Class Ib in Autoimmunity
Dysregulated MHC class Ib binding can contribute to autoimmune diseases by altering NK cell tolerance and activation [1, 5]. For instance, polymorphisms in HLA-E that affect peptide binding and receptor interaction have been associated with susceptibility to autoimmune disorders. Understanding these interactions may lead to novel treatments for autoimmunity.
MHC Class Ib in Infectious Diseases
Pathogens can modulate MHC class Ib expression or function to evade immune detection [3, 6]. For example, viruses may interfere with peptide loading onto class Ib molecules or downregulate their surface expression. The interaction between H2-Q10 and Ly49C is important for controlling mouse cytomegalovirus infection, demonstrating the role of class Ib binding in antiviral immunity.

From MHC class Ib protein complex binding-Related Genes to Experimental Models

Research QuestionSuitable Model
Does HLA-E binding to NKG2A inhibit NK cell cytotoxicity?HLA-E knockout in human NK cells; NKG2A blockade
What is the role of H2-Q10 in antiviral immunity?H2-Q10 knockout mice infected with MCMV
How does TL act as a tumor antigen?TL-overexpressing tumor cell lines in syngeneic mice
What peptides are presented by MHC class Ib?Knock-in of tagged HLA-E; mass spectrometry
How do point mutations affect receptor binding?CRISPR point mutation in HLA-E or H2-Q10 [1, 3]
Can overexpression of HLA-G induce tolerance?HLA-G transgenic mice; skin graft models

How to Study the MHC class Ib protein complex binding Process

MethodWhat It MeasuresTypical Application
X-ray crystallography3D structure of protein complexesDetermine binding interface of HLA-E with NKG2A
Surface plasmon resonanceBinding affinity and kineticsQuantify H2-Q10-Ly49C interaction
CRISPR knockoutLoss of gene functionStudy requirement of B2M for MHC class Ib surface expression
CRISPR knock-inIntroduction of specific mutationsTag endogenous HLA-E for imaging
Flow cytometryCell surface expression and bindingAnalyze HLA-E expression on tumor cells
Mass spectrometryPeptide repertoire of MHC class IbIdentify peptides presented by HLA-E
RNA-seqTranscriptional profilingAssess class Ib gene expression in tumors
BioinformaticsPrediction of peptide bindingIdentify potential MHC class Ib ligands
Structural Biology (X-ray Crystallography, Cryo-EM)
Structural studies reveal the atomic details of MHC class Ib binding to receptors, as demonstrated for HLA-E and Ly49C [1, 3]. These methods identify key contact residues and conformational changes.
Surface Plasmon Resonance (SPR) and Isothermal Titration Calorimetry (ITC)
These biophysical techniques measure binding affinity and kinetics between MHC class Ib complexes and their ligands [1, 3]. They are used to quantify the impact of mutations on binding.
CRISPR-Cas9 Genome Editing
CRISPR knockout, knock-in, and point mutation models enable functional dissection of MHC class Ib binding in cell lines and animal models [1, 3]. These approaches help identify genes essential for binding and downstream signaling.
Flow Cytometry and Tetramer Staining
Flow cytometry with peptide-MHC tetramers detects antigen-specific T cells and NK cells, allowing assessment of MHC class Ib binding in primary cells [1, 5].

How CRISPR Can Be Used to Study GO:0023025 MHC class Ib protein complex binding

Knockout

CRISPR knockout of MHC class Ib genes (e.g., HLA-E, H2-Q10) or their receptors (e.g., NKG2A) abolishes binding interactions, enabling loss-of-function studies in immune cells and tumor models [1, 3]. This approach helps determine the contribution of specific binding events to immune responses.

Point Mutation

Introducing point mutations in the binding interface of MHC class Ib molecules or their receptors via CRISPR allows precise mapping of residues critical for interaction [1, 3]. Such models are valuable for understanding specificity and affinity.

Knock-in

Knock-in of tagged or humanized MHC class Ib genes (e.g., HLA-E in mice) facilitates tracking and functional studies in vivo. This approach can also be used to express mutant variants under endogenous regulatory elements.

Overexpression

CRISPR-mediated overexpression of MHC class Ib molecules or their ligands can model pathological states such as tumor immune evasion or autoimmunity [1, 8]. Overexpression in cell lines or transgenic animals helps study gain-of-function effects.

How EDITGENE Supports MHC class Ib protein complex binding Research

Researchers studying MHC class Ib protein complex binding-related genes often need to determine whether a candidate gene is causally involved in immune recognition, antigen presentation, or disease progression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling functional validation of binding interactions and downstream pathways.
Contact EDITGENE today to design your custom CRISPR model for MHC class Ib protein complex binding research.

Frequently Asked Questions About MHC class Ib protein complex binding

It is a molecular function (GO:0023025) defined as the binding to a class Ib major histocompatibility complex protein, which is involved in immune recognition and antigen presentation [1, 5].
Key genes include HLA-E, H2-Q10, TL, Ly49C, CD94, NKG2A, and B2M, among others [1, 3, 8].
MHC class Ib molecules are nonclassical, less polymorphic, and have specialized immune functions, such as presenting restricted peptides to NK cell receptors [1, 6].
Dysregulation is linked to cancer, autoimmune diseases, and infectious diseases [1, 8].
Methods include X-ray crystallography, surface plasmon resonance, CRISPR knockout/knock-in, flow cytometry, and mass spectrometry [1, 3].
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models enable precise functional studies of binding interactions [1, 3].
HLA-E binds to CD94/NKG2 receptors on NK cells, delivering inhibitory or activating signals that regulate NK cell cytotoxicity [1, 5].
H2-Q10 is a mouse MHC class Ib molecule that binds to the Ly49C receptor, modulating NK cell responses during viral infection.
TL is a mouse MHC class Ib molecule that can act as a tumor-specific antigen, eliciting T cell responses against tumors.
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to study MHC class Ib protein complex binding [1, 3].

Conclusion

MHC class Ib protein complex binding (GO:0023025) is a fundamental molecular function that governs immune recognition through interactions between nonclassical MHC molecules and their receptors [1, 5]. Its roles in NK cell regulation, antigen presentation, and disease pathogenesis make it a critical area of research [1, 3, 8]. Advanced CRISPR tools and structural biology approaches continue to unravel the complexities of these binding events, offering new avenues for therapeutic intervention [1, 3].

References

  1. 1. Gillespie GM et al.. 2025. HLA-E: Immune Receptor Functional Mechanisms Revealed by Structural Studies.. Immunol Rev 329(1):e13434 PMID: 39753525
  2. 2. Howcroft T et al.. 2003. Expression of nonclassical MHC class Ib genes: comparison of regulatory elements.. Immunol Res 27(1):1-30 PMID: 12637766
  3. 3. Sullivan LC et al.. 2016. Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.. J Biol Chem 291(36):18740-52 PMID: 27385590
  4. 4. Obara I et al.. 2023. The antigen recognition portion of African buffalo class I MHC is highly polymorphic, consistent with a complex pathogen challenge environment, and the 3' region suggests distinct haplotype configurations.. Immunogenetics 75(2):115-132 PMID: 36512055
  5. 5. Borrego F et al.. 2002. Structure and function of major histocompatibility complex (MHC) class I specific receptors expressed on human natural killer (NK) cells.. Mol Immunol 38(9):637-60 PMID: 11858820
  6. 6. Shawar SM et al.. 1994. Antigen presentation by major histocompatibility complex class I-B molecules.. Annu Rev Immunol 12:839-80 PMID: 8011299
  7. 7. Yeager M et al.. 1997. Sequence convergence in the peptide-binding region of primate and rodent MHC class Ib molecules.. Mol Biol Evol 14(10):1035-41 PMID: 9335143
  8. 8. Tsujimura K et al.. 2004. Thymus-leukemia antigen (TL) as a major histocompatibility complex (MHC) class Ib molecule and tumor-specific antigen.. Cancer Sci 95(6):469-74 PMID: 15182425
Contact Us
*
*
*
*
How did you hear about us: